Evolve BioSystems is an infant microbiome company dedicated to developing the next generation of products to establish, restore and maintain a healthy gut microbiome. The foundation is working with Evolve to further develop and apply its lead probiotic, Evivo, to Read More
June 12, 2018 DAVIS, Calif., June 13, 2018 /PRNewswire/ — Evolve BioSystems, Inc., the leading infant gut microbiome company, today announced that it has completed a $40 million Series C round of funding co-led by the Bill & Melinda Gates Foundation, Read More
Synlogic is a start-up company in Boston, developing a first-in-class synthetic biology platform for genetically engineering bacteria of the microbiome for delivery of therapeutics to the gut, initially focused on metabolic imbalance and inflammatory disease.
January 14, 2018 Zambia’s government says it will ease some of the emergency measures it introduced to stamp out a cholera outbreak that has killed at least 72 people. Al Jazeera looks at how health workers are delivering new solutions Read More
The Stanford Social Innovation Review explores how the Bill & Melinda Gates Foundation uses strategic investments for social impact. Read the full report here. Chapters: Philanthropy’s New Tools for Innovation and Impact Leveraging the Balance Sheet Neglected No More Unintended Read More